Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Ri Kim

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Biomolecules & Therapeutics|June 10, 2025
Niclosamide Alleviated Skin Inflammation and Restored the Balance between Effector and Regulatory T Cells in SkinBo Mi Kang, Eunyoung Seo, Jung Min Ahn, et al.
Ecotoxicology and Environmental Safety|August 10, 2025
Development and application of an LC-MS/MS method for urinary DNA adduct profiling in residents of environmentally vulnerable areasBo-Ri Kim, Jeong-Kyu Ji, Jang-Hun Jeong, et al.
Molecules (Basel, Switzerland)|June 28, 2023
Structure-Guided Development of Bivalent Aptamers Blocking SARS-CoV-2 InfectionMd Shafiqur Rahman, Min Jung Han, Sang Won Kim, et al.
Environmental Research|April 30, 2026
Associations Between Environmental Metal Mixture Exposure and Urinary DNA Adduct Biomarkers of Oxidative and Alkylative Damage in AdultsJang-Hun Jeong, Bo-Ri Kim, Jeong-Kyu Ji, et al.
The Journal of Dermatological Treatment|April 14, 2024
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participantsBo Ri Kim, Min Jae Kim, Jieun Koo, et al.
The Journal of Dermatology|November 20, 2016
Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasisYoung Ji Hwang, Sang Woong Youn, Bo Ri Kim, et al.
Scientific Reports|August 19, 2025
Optimizing mobile cognitive assessment reduces administration time while maintaining screening accuracy in older adultsHyun Jeong Ko, Jin Sung Kim, Whani Kim, et al.
Annals of Dermatology|January 29, 2026
Assessing Laser Safety in Dermatology: Eye Protection and Infection Control Practices Among Board-Certified Korean DermatologistsSejin Oh, Yeong Ho Kim, Bo Ri Kim, et al.
Scientific Reports|September 28, 2022
The degradation of performance of a state-of-the-art skin image classifier when applied to patient-driven internet searchSeung Seog Han, Cristian Navarrete-Dechent, Konstantinos Liopyris, et al.
Frontiers in Immunology|June 3, 2025
A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with <i>Post-hoc</i> biomarker analysisGyeong Ho Baek, Bo Ri Kim, Jung-Won Shin, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Biomolecules & Therapeutics|June 10, 2025
Niclosamide Alleviated Skin Inflammation and Restored the Balance between Effector and Regulatory T Cells in SkinBo Mi Kang, Eunyoung Seo, Jung Min Ahn, et al.
Ecotoxicology and Environmental Safety|August 10, 2025
Development and application of an LC-MS/MS method for urinary DNA adduct profiling in residents of environmentally vulnerable areasBo-Ri Kim, Jeong-Kyu Ji, Jang-Hun Jeong, et al.
Molecules (Basel, Switzerland)|June 28, 2023
Structure-Guided Development of Bivalent Aptamers Blocking SARS-CoV-2 InfectionMd Shafiqur Rahman, Min Jung Han, Sang Won Kim, et al.
Environmental Research|April 30, 2026
Associations Between Environmental Metal Mixture Exposure and Urinary DNA Adduct Biomarkers of Oxidative and Alkylative Damage in AdultsJang-Hun Jeong, Bo-Ri Kim, Jeong-Kyu Ji, et al.
The Journal of Dermatological Treatment|April 14, 2024
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participantsBo Ri Kim, Min Jae Kim, Jieun Koo, et al.
The Journal of Dermatology|November 20, 2016
Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasisYoung Ji Hwang, Sang Woong Youn, Bo Ri Kim, et al.
Scientific Reports|August 19, 2025
Optimizing mobile cognitive assessment reduces administration time while maintaining screening accuracy in older adultsHyun Jeong Ko, Jin Sung Kim, Whani Kim, et al.
Annals of Dermatology|January 29, 2026
Assessing Laser Safety in Dermatology: Eye Protection and Infection Control Practices Among Board-Certified Korean DermatologistsSejin Oh, Yeong Ho Kim, Bo Ri Kim, et al.
Scientific Reports|September 28, 2022
The degradation of performance of a state-of-the-art skin image classifier when applied to patient-driven internet searchSeung Seog Han, Cristian Navarrete-Dechent, Konstantinos Liopyris, et al.
Frontiers in Immunology|June 3, 2025
A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with <i>Post-hoc</i> biomarker analysisGyeong Ho Baek, Bo Ri Kim, Jung-Won Shin, et al.
Pageof 8